Boji Medical Technology Co

Boji Medical Technology Co PEG

The PEG Ratio (Price/Earnings-to-Growth) of Boji Medical Technology Co (300404.SZ) as of Nov 3, 2026 is 39.22. In the previous year, PEG Ratio (Price/Earnings-to-Growth) was 41.56 — a change of -5.63% (lower).

PEG

39.22

YoY

-5.63%

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Boji Medical Technology Co is 2025 39.22 . PEG Ratio (Price/Earnings-to-Growth) of Boji Medical Technology Co was 2024 41.56 . It decreases by -5.63% lower compared to the previous year.

The Boji Medical Technology Co PEG history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PEG
Date
PEG
Jan 1, 2018
161.61 CNY
Jan 1, 2019
181.40 CNY
Jan 1, 2020
70.39 CNY
Jan 1, 2021
30.76 CNY
Jan 1, 2022
43.22 CNY
Jan 1, 2023
49.13 CNY
Jan 1, 2024
41.56 CNY
Jan 1, 2025
39.22 CNY
The Boji Medical Technology Co PEG history
YEARPEGYoY
39.22-5.63%
41.56-15.42%
49.13+13.68%
43.22+40.52%
30.76-56.31%
70.39-61.19%
181.40+12.25%
161.61-71.80%
572.99+1,129.65%
46.60+47.93%
31.50—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Boji Medical Technology Co Stock analysis

What does Boji Medical Technology Co do? Boji Medical Technology Co., Ltd. generates revenue through comprehensive CRO services for pharmaceutical and medical device development. The company offers preclinical research, clinical trials, data management, biostatistics, and regulatory consulting, primarily serving domestic pharmaceutical companies and research institutions. Their one-stop service model includes drug evaluation, medical device registration, and CDMO services for new drug and device production. The firm's domestic market focus ensures steady demand from local clients seeking regulatory compliance and R&D support. The company's revenue streams are derived from multiple service segments: preclinical studies, clinical research, and technology transfer. These services are tailored to meet the needs of pharmaceutical firms requiring outsourced R&D solutions. CDMO services further enhance their offerings by supporting manufacturing processes alongside development. Domestic clients form the core customer base, leveraging Boji's expertise in navigating China's regulatory landscape for drug and device approvals. Boji Medical Technology's business model centers on providing end-to-end CRO solutions, combining preclinical and clinical research with regulatory support. Their services are designed to accelerate product development cycles for clients, reducing time-to-market for new pharmaceuticals and medical devices. The firm's domestic market strategy aligns with the growing demand for R&D outsourcing within China's healthcare sector. Boji Medical Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Boji Medical Technology Co stock

PEG Ratio (Price/Earnings-to-Growth) of Boji Medical Technology Co is 39.22 in 2025.

PEG Ratio (Price/Earnings-to-Growth) of Boji Medical Technology Co changed from 41.56 to 39.22, representing a -5.63% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Boji Medical Technology Co since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Boji Medical Technology Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Boji Medical Technology Co

All Key Metrics — Boji Medical Technology Co